好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Anterior Horn: Basic Science

Thursday 04/15/10
02:45 PM - 03:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Anterior Horn
No CME available
Event Timeline
02:45 PM - 03:45 PM Abstract 001 - Cytoplasmic C-Terminus TDP-43 Aggregate Leads to Increased Phosphorylation of Full-Length TDP-43 in Culture Cell
02:45 PM - 03:45 PM Abstract 002 - Microglial Transformation from a Motoneuron Protective to a Toxic Phenotype in a Mouse Model of ALS
02:45 PM - 03:45 PM Abstract 003 - Prion-Like Propagation of SOD1 Misfolding [italic]In Vitro[/italic]
02:45 PM - 03:45 PM Abstract 004 - CD4+ T-Cells Induce Alternatively Activated (M2) Microglia in the ALS Mouse
Faculty Disclosures
No disclosure on file
Osamu Onodera, MD Dr. Onodera has nothing to disclose.
David R. Beers, PhD No disclosure on file
Tomohiko Ishihara Tomohiko Ishihara has nothing to disclose.
Neil Cashman, MD Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONIS. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care.
Masatoyo Nishizawa, MD No disclosure on file
Weihua Zhao, MD No disclosure on file
Baki Goksan, PhD No disclosure on file
Yuksel Kablan No disclosure on file
Bing Liao, MD The institution of Dr. Liao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenex.
Jenny Henkel, PhD No disclosure on file
Martina Wiedau-Pazos, MD No disclosure on file
Bijen Nazliel No disclosure on file
Timothy M. Miller, MD, PhD Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Bio. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. The institution of Dr. Miller has received research support from Ionis Pharmaceuticals . Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Yuko Ariizumi No disclosure on file
Stanley H. Appel, MD, FAAN Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.